DIAGNOSTIC ACCURACY OF CONFOCAL LASER ENDOMICROSCOPY FOR PANCREATIC DUCTAL ADENOCARCINOMA, AN EX-VIVO PILOT STUDY

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggresive tumors, with a 20 to 25% survival rate in a resectable stage. Moreover, providing a precise resection margin ensures a better prognosis. Probe based confocal laser endomicroscopy (pCLE), with various miniprobes available is being used as a prehistopathological tool for different types of lesions. However, in PDAC there is limited experience in imaging studies.